Clinical Neurophysiology

Promoting Education and Attainment of the Highest Level of Knowledge and Understanding of Clinical Neurophysiology

The International Federation of Clinical Neurophysiology (IFCN) has member societies in 62 countries. The IFCN mission is to promote best practice in clinical neurophysiology through education and research throughout the world. And our vision is to improve healthcare worldwide by understanding the nervous system and optimizing the diagnosis and treatment of its disorders through clinical neurophysiology.

Clinical Neurophysiology is the official journal of IFCN and its member Societies. It has been adopted as the official journal of the Italian Society of Clinical Neurophysiology, the Czech Society of Clinical Neurophysiology, the Brazilian Society of Clinical Neurophysiology and the International Society of Intraoperative Neurophysiology.

To secure an individual subscription to Clinical Neurophysiology, please click here.  

All studies published in Clinical Neurophysiology must stand on their own and make a substantial contribution to the literature.  The journal does not afford a high priority to ‘pilot’ or ‘preliminary’ studies or to negative studies that do not advance knowledge.

For author guidelines and other data on the journal or to submit a manuscript, please click here.

Scope of the Journal

  • Clinical Neurophysiology is dedicated to publishing scholarly reports on the pathophysiology underlying diseases of the peripheral and central nervous system of humans. Reports on clinical trials that use neurophysiological measures as endpoints are encouraged, as are manuscripts on integrated neuroimaging of peripheral and central nervous function including, but not limited to, functional MRI, brain mapping, MEG, EEG, PET, ultrasound, and other neuroimaging modalities. Studies on normal human neurophysiology are welcome, if they link to disease or clinical applications. Studies on animals and technical reports must have clear applicability to human disease. Case reports may be considered (exclusively as Letters-to-the-Editor), if implying substantial advancement of knowledge. 

  • Clinical Neurophysiology covers epilepsy, developmental clinical neurophysiology, psychophysiology and psychopathology, motor control and movement disorders, somatosensory disorders including pain, motor neuron diseases, neuromuscular diseases, neuropathies, sleep and disorders of consciousness, auditory and vestibular disorders, aging, Alzheimer’s disease, other dementias, other psychiatric disorders, autonomic disorders, neural plasticity and recovery, intraoperative and ICU monitoring, and therapeutic clinical neurophysiology including non-invasive and invasive brain stimulation. However the journal is not a methodological journal, and studies reporting normative data collected with routine neurophysiological procedures are of low priority.

  • Reviews of topical areas from recognised experts are normally invited by the Editor-in-Chief, on the recommendations of the Associate Editors and Editorial Board, and are subject to full peer review.

  • The Senior Editors now will consider Case Reports only as Letters. They will however be fully peer-reviewed, as will letters commenting on published papers.

Journal Standing

  • 2017 JCR Impact Factor: 3.614
  • Ranking of IF in Clinical Neurology: 53th of 197
  • Total Citations: 18,399
  • Total Articles: 265
  • Eigenfactor Score: 0.02307
  • Immediacy Index: 0.992
    5 yrs- impact factor: 3.638

As explained in Wikipedia: “The Eigenfactor approach is thought to be more robust than the impact factor metric, which purely counts incoming citations without considering the significance of those citations. ….. journals are rated according to the number of incoming citations, with citations from highly-ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly-ranked journals.”

Editorial Board

• Editor-in-Chief:

Ulf Ziemann (Tübingen, Germany)

• Current Associate Editors:

Robert J. Barry (Wollongong, Australia)
James G. Colebatch (Sydney, Australia)
Zafiris J. Daskalakis (Toronto, Canada)
Olivia Gosseries (Liége, Belgium)
Christian Krarup (Copenhagen, Denmark)           
Ron Lesser (Baltimore, USA)
David MacDonald (Riyadh, Saudi Arabia)
Hartwig R. Siebner (Copenhagen, Denmark)
John-Stuart Brittain (Oxford, UK)
Andrea Truini (Rome, Italy)
Yoshikazu Ugawa (Fukushima, Japan)

• Current Management Board:

Members of the Executive Committee, IFCN

• Current Editorial Board:

M. Abe Sendai, Japan
B. Abou-Khalil Nashville, USA
O. Bai Richmond, USA
M. Ballegaard Copenhagen, Denmark
M. Bares Brno, Czech Republic
L. Bateman New York, USA
U. Baumgaertner Mannheim, Germany
A. Bendixen Chemnitz, Germany
S. Biswas London, UK
J. Bragatti Porto Alegre, Brazil
L. Chen Sydney, Australia
C. Chu Boston, USA
V. Deletis New York, USA
S. Dimitriadis Cardiff, UK
E. Donchin Tampa, USA
S. Finnigan Brisbane, Australia
S. Franceschetti Milan, Italy
H. Franssen Utrecht, Netherlands
A. Grimm Tübingen, Germany
A.G. Guggisberg Geneva, Switzerland
C. Hawco Toronto, Canada
L. Hobson-Webb Durham, USA
S. Hoppenbrouwers Amsterdam, NL
R. Ishii Osaka, Japan
J. Jacobs Freiburg, Germany
M. Kinoshita Kyoto, Japan
M. Knikou Staten Island, USA

J. Kraus Prague, Czech Republic
D.J. Krusienski Norfolk, USA
S. Lewis Sydney, Australia
T. Lett Berlin, Germany
D. Mathersul Palo Alto, USA
R. Matsumoto Kyoto, Japan
T. Murakami Fukushima, Japan
T. Murofushi Kawaskai, Japan
M. Nakamura Yokohama, Japan
N. Nakasato Sendai, Japan
S. Nandedkar Hopewell Junction, USA
S. Olbrich Leipzig, Germany
M. Ozgoren Izmir, Turkey
E.S. Papathanasiou Nicosia, Greece
G. Pellegrino Venice, Italy
T. Rajji Toronto, Canada
S. Rampp Erlangen, Germany
S. Rosengren Sydney, Australia
Y. Shirota Tokyo, Japan
M. Stecker Mineola, USA
A. Suppa Rome, Italy
A. Szelenyi München, Germany
M. Takemi Kanagawa, Japan
L. Tomasevic Copenhagen, Denmark
O. Vucic Wentworthville, Australia
R. Zomorrodi Toronto, Canada  

Close Menu